Ivelin Georgiev

  • social distancing

    Children’s antibodies highly potent against COVID-19: study

    Reporting Nov. 6 in Cell Reports Medicine, Ivelin Georgiev, PhD, and colleagues demonstrated that antibodies isolated from children’s blood samples displayed high levels of neutralization and potency against variants of the COVID-19 virus, SARS-CoV-2, even when the children had not previously been exposed to or vaccinated against those variants. Read More

    Nov 6, 2023

  • COVID Research

    Vanderbilt team tracks cellular and antibody responses to COVID-19 vaccine

    A collaborative team of Vanderbilt researchers has characterized the antigen-specific immune response to the Pfizer SARS-CoV-2 RNA vaccine. The group used multiple single-cell technologies, unbiased machine learning and traditional immunological approaches to track cellular and antibody responses in samples collected over time from a cohort of healthy participants. Read More

    Jul 20, 2022

  • Vanderbilt University

    “Ultra-potent” antibody against COVID-19 variants isolated at VUMC

    A technology developed at Vanderbilt has led to the discovery of an “ultra-potent” monoclonal antibody against multiple variants of SARS-CoV-2, the virus responsible for COVID-19, including the delta variant. Read More

    Sep 22, 2021

  • Vanderbilt University

    Grant helps expand VI4’s Artist-in-Residence program

    An innovative Vanderbilt program that brings together scientists and artists with the shared goal of scientific communication is set to expand with support from a three-year grant from the Burroughs Wellcome Fund. Read More

    Oct 29, 2020

  • Chancellor Faculty Fellows

    10 faculty members named as 2020 Chancellor Faculty Fellows

    Ten outstanding faculty members from across the university have been selected for the 2020 cohort of Chancellor Faculty Fellows. This group is composed of highly accomplished, recently tenured faculty from a wide variety of disciplines and areas of expertise. Read More

    Jun 19, 2020

  • Artificial intelligence concept showing 0's and 1's flowing into head networked like a circuit board

    New tool may speed antibody, vaccine research

    Antibody discovery and vaccine development research may be on the verge of rapidly expanding with data that previously took decades to acquire, thanks to LIBRA-seq, a new tool developed by Vanderbilt University researchers and their colleagues. Read More

    Dec 12, 2019

  • HIV virus

    A “public” target for HIV

    Common sequences of antibodies against HIV may be key to developing a successful vaccine strategy for the virus. Read More

    Jun 8, 2018